NeuPath Health Inc.

TSXV:NPTH Voorraadrapport

Marktkapitalisatie: CA$9.0m

NeuPath Health Inkomsten in het verleden

Verleden criteriumcontroles 0/6

NeuPath Health has been growing earnings at an average annual rate of 37.1%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 5.9% per year.

Belangrijke informatie

37.1%

Groei van de winst

62.8%

Groei van de winst per aandeel

Healthcare Groei van de industrie-6.7%
Inkomstengroei5.9%
Rendement op eigen vermogen0.03%
Nettomarge-0.1%
Volgende winstupdate14 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Aug 18
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16
These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Apr 23
The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01
Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Dec 20
Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Aug 19
Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Opbrengsten en kosten

Hoe NeuPath Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

TSXV:NPTH Opbrengsten, kosten en inkomsten (CAD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24690100
31 Mar 2468090
31 Dec 2366090
30 Sep 2365-290
30 Jun 2365-390
31 Mar 2363-390
31 Dec 2263-490
30 Sep 2262-3100
30 Jun 2262-3100
31 Mar 2262-3100
31 Dec 2161-3100
30 Sep 2158-3100
30 Jun 2155-390
31 Mar 2150-590
31 Dec 2048-580
30 Sep 2048-780
30 Jun 2049-880
31 Mar 2050-580
31 Dec 1950-580
31 Dec 1840-580
31 Dec 1720-460

Kwaliteitswinsten: NPTH is currently unprofitable.

Groeiende winstmarge: NPTH is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: NPTH is unprofitable, but has reduced losses over the past 5 years at a rate of 37.1% per year.

Versnelling van de groei: Unable to compare NPTH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: NPTH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).


Rendement op eigen vermogen

Hoge ROE: NPTH has a negative Return on Equity (0.027%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden